If you made any changes in Pure these will be visible here soon.

Research Output 1989 2019

  • 19015 Citations
  • 63 h-Index
  • 308 Article
  • 7 Review article
  • 3 Letter
  • 1 Chapter
Filter
Article
2019

Exploiting FAsting-mimicking Diet and MEtformin to Improve the Efficacy of Platinum-pemetrexed Chemotherapy in Advanced LKB1-inactivated Lung Adenocarcinoma: The FAME Trial

Vernieri, C., Signorelli, D., Galli, G., Ganzinelli, M., Moro, M., Fabbri, A., Tamborini, E., Marabese, M., Caiola, E., Broggini, M., Hollander, L., Gallucci, R., Vandoni, G., Gavazzi, C., Triulzi, T., Colombo, M. P., Rizzo, A. M., Corsetto, P. A., Pruneri, G., de Braud, F. & 3 others, Sozzi, G., Torri, V. & Garassino, M. C., May 2019, In : Clinical Lung Cancer. 20, 3, p. e413-e417

Research output: Contribution to journalArticle

Pemetrexed
Metformin
Platinum
Fasting
Phosphotransferases

Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies

Cazzaniga, M. E., Verusio, C., Ciccarese, M., Fumagalli, A., Sartori, D., Valerio, M. R., Airoldi, M., Moretti, G., Ficorella, C., Gianni, L., Michelotti, A., Zambelli, A., Febbraro, A., Generali, D., Pistelli, M., Garrone, O., Musolino, A., Vici, P., Maur, M., Mentuccia, L. & 31 others, La Verde, N., Bianchi, G. V., Artale, S., Blasi, L., De Laurentiis, M., Atzori, F., Turletti, A., Porpiglia, M., Santini, D., Fabi, A., Gebbia, V., Schirone, A., Palumbo, R., Ferzi, A., Frassoldati, A., Scavelli, C., Clivio, L., Giordano, M., Donadio, M., Biganzoli, L., Del Mastro, L., Bisagni, G., Livi, L., Natoli, C., Montemurro, F., Riccardi, F., Romagnoli, E., Marchetti, P., Torri, V., Pronzato, P. & Mustacchi, G., Jan 1 2019, In : Breast Care.

Research output: Contribution to journalArticle

Extravehicular Activity
Breast Neoplasms
Therapeutics
Aromatase Inhibitors
Datasets
3 Citations (Scopus)

MariX, an advanced MHz-class repetition rate X-ray source for linear regime time-resolved spectroscopy and photon scattering

Serafini, L., Bacci, A., Bellandi, A., Bertucci, M., Bolognesi, M., Bosotti, A., Broggi, F., Calandrino, R., Camera, F., Canella, F., Capra, S., Cardarelli, P., Carrara, M., Cassou, K., Castoldi, A., Castriconi, R., Cattaneo, G. M., Cialdi, S., Cianchi, A., Coluccelli, N. & 30 others, Curatolo, C., Del Vecchio, A., Di Mitri, S., Drebot, I., Dupraz, K., Esposito, A., Faillace, L., Ferrario, M., Fiorini, C., Galzerano, G., Gambaccini, M., Ghiringhelli, G., Giannotti, D., Giove, D., Groppi, F., Guazzoni, C., Laporta, P., Leoni, S., Loria, A., Mazza, T., Meroni, C., Pagani, C., Perini, L., Petrarca, M., Rossi, A. R., Rossi, L., Russo, P., Torri, V., Valdagni, R. & Rossi, G., Jun 21 2019, In : Nuclear Instruments and Methods in Physics Research, Section A: Accelerators, Spectrometers, Detectors and Associated Equipment. 930, p. 167-172 6 p.

Research output: Contribution to journalArticle

repetition
Photons
Spectroscopy
Scattering
X rays
8 Citations (Scopus)

Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors

Fucà, G., Galli, G., Poggi, M., Lo Russo, G., Proto, C., Imbimbo, M., Ferrara, R., Zilembo, N., Ganzinelli, M., Sica, A., Torri, V., Colombo, M. P., Vernieri, C., Balsari, A., De Braud, F., Garassino, M. C. & Signorelli, D., Feb 1 2019, In : ESMO Open. 4, 1, e000457.

Research output: Contribution to journalArticle

Open Access
Non-Small Cell Lung Carcinoma
Blood Cells
Steroids
Neutrophils
Lymphocytes

Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer

Colombo, N., Zaccarelli, E., Baldoni, A., Frezzini, S., Scambia, G., Palluzzi, E., Tognon, G., Lissoni, A. A., Rubino, D., Ferrero, A., Farina, G., Negri, E., Pesenti Gritti, A., Galli, F., Biagioli, E., Rulli, E., Poli, D., Gerardi, C., Torri, V., Fossati, R. & 1 others, D'Incalci, M., Sep 20 2019, In : British Journal of Cancer.

Research output: Contribution to journalArticle

trabectedin
Carboplatin
Platinum
Ovarian Neoplasms
Safety

Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma

Italian Association of Neuro-Oncology, May 6 2019, In : Journal of Neuro-Oncology. 142, 3, p. 455-62 8 p.

Research output: Contribution to journalArticle

Glioblastoma
temozolomide
Disease-Free Survival
IDN 5109
Recurrence

Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma

the Italian Association of Neuro-Oncology, Silvani, A., De Simone, I., Fregoni, V., Biagioli, E., Marchioni, E., Caroli, M., Salmaggi, A., Pace, A., Torri, V., Gaviani, P., Quaquarini, E., Simonetti, G., Rulli, E. & D’Incalci, M., Jan 1 2019, In : Journal of Neuro-Oncology. 142, 3, p. 455-462

Research output: Contribution to journalArticle

Glioblastoma
temozolomide
Disease-Free Survival
IDN 5109
Recurrence
Open Access
eribulin
anthracyclines
Triple Negative Breast Neoplasms
taxanes
Catenins

Oral maintenance metronomic vinorelbine versus best supportive care in advanced non-small-cell lung cancer after platinum-based chemotherapy: The MA.NI.LA. multicenter, randomized, controlled, phase II trial

Platania, M., Pasini, F., Porcu, L., Boeri, M., Verderame, F., Modena, Y., Del Conte, A., Nichetti, F., Garassino, M. C., Martinetti, A., Sottotetti, E., Cavanna, L., Vattemi, E., Pozzessere, D., Bertolini, A., Irtelli, L., Verri, C., Sozzi, G., Proto, C., Pastorino, U. & 12 others, Torri, V., Fraccon, A. P., Spinnato, F., Signorelli, D., Lo Russo, G., Tuzi, A., Gallucci, R., Cinieri, S., Mencoboni, M., Antonelli, P., Giacomelli, L. & de Braud, F., Jun 2019, In : Lung Cancer. 132, p. 17-23 7 p.

Research output: Contribution to journalArticle

Platinum
Non-Small Cell Lung Carcinoma
Maintenance
Drug Therapy
Disease-Free Survival

The 41-gene classifier TRAR predicts response of HER2 positive breast cancer patients in the NeoALTTO study

Di Cosimo, S., Triulzi, T., Pizzamiglio, S., De Cecco, L., de Azambuja, E., Fumagalli, D., Putzai, L., Harbeck, N., Izquierdo, M., Peña, L. D. L., Daidone, M. G., Huober, J., Gori, S., Cinieri, S., Torri, V., Baselga, J., Piccart, M., de Braud, F. G., Apolone, G., Verderio, P. & 1 others, Tagliabue, E., Sep 2019, In : European Journal of Cancer. 118, p. 1-9 9 p.

Research output: Contribution to journalArticle

Open Access
Breast Neoplasms
Area Under Curve
ROC Curve
Genes
Therapeutics
2 Citations (Scopus)
Colonic Neoplasms
Neoplasms
Therapeutics
Survival
Disease-Free Survival
2018
11 Citations (Scopus)
exemestane
letrozole
Tamoxifen
Aromatase Inhibitors
Breast Neoplasms

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

De Placido, S., Gallo, C., De Laurentiis, M., Bisagni, G., Arpino, G., Sarobba, M. G., Riccardi, F., Russo, A., Del Mastro, L., Cogoni, A. A., Cognetti, F., Gori, S., Foglietta, J., Frassoldati, A., Amoroso, D., Laudadio, L., Moscetti, L., Montemurro, F., Verusio, C., Bernardo, A. & 209 others, Lorusso, V., Gravina, A., Moretti, G., Lauria, R., Lai, A., Mocerino, C., Rizzo, S., Nuzzo, F., Carlini, P., Perrone, F., Accurso, A., Agostara, B., Aieta, M., Alabiso, O., Alicicco, M. G., Amadori, D., Amaducci, L., Amiconi, G., Antuzzi, G., Ardine, M., Ardizzoia, A., Aversa, C., Badalamenti, G., Barni, S., Basurto, C., Berardi, R., Bergamasco, C., Bidoli, P., Bighin, C., Biondi, E., Bisagni, G., Boni, C., Borgonovo, K., Botta, M., Bravi, S., Bruzzi, P., Buono, G., Butera, A., Caldara, A., Candeloro, G., Cappelletti, C., Cardalesi, C., Carfora, E., Cariello, A., Carrozza, F., Cartenì, G., Caruso, M., Casadei, V., Casanova, C., Castori, L., Cavanna, L., Cavazzini, G., Cazzaniga, M., Chilelli, M., Chiodini, P., Chiorrini, S., Ciardiello, F., Ciccarese, M., Cinieri, S., Clerico, M., Coccaro, M., Comande, M., Corbo, C., Cortino, G., Cusenza, S., Daniele, G., D'arco, A. M., D'auria, G., Dazzi, C., De Angelis, C., de Braud, F., De Feo, G., De Matteis, A., De Tursi, M., Di Blasio, A., di Lucca, G., Di Lullo, L., Di Rella, F., Di Renzo, G., Di Stefano, P., Di Stefano, A., Diana, A., Donati, S., Fabbri, A., Fabi, A., Faedi, M., Farina, G., Farris, A., Febbraro, A., Fedele, P., Federico, P., Ferraù, F., Ferretti, G., Ferro, A., Floriani, I., Forcignanò, R., Forciniti, S., Forestieri, V., Fornari, G., Frisinghelli, M., Fusco, V., Gallizzi, G., Galvano, A., Gambardella, A., Gambi, A., Gebbia, V., Gervasi, E., Ghilardi, M., Giacobino, A., Giardina, G., Giotta, F., Giraudi, S., Giuliano, M., Grassadonia, A., Grasso, D., Grosso, F., Guizzaro, L., Incoronato, P., Incorvaia, L., Iodice, G., La Verde, N., Labonia, V., Landi, G., Latorre, A., Leonardi, V., Levaggi, A., Limite, G., Lina Bascialla, L., Livi, L., Maiello, E., Mandelli, D., Marcon, I., Menon, D., Montedoro, M., Moraca, L., Moretti, A., Morritti, M. G., Morselli, P., Mura, A., Mura, S., Musacchio, M., Muzio, A., Natale, D., Natoli, C., Nigro, C., Nisticò, C., Nuzzo, A., Orditura, M., Orlando, L., Pacilio, C., Palumbo, G., Palumbo, R., Pasini, F., Paterno, E., Pazzola, A., Pelliccioni, S., Pensabene, M., Perroni, D., Pesenti Gritti, A., Petrelli, F., Piccirillo, M. C., Pinotti, G., Pogliani, C., Poli, D., Prader, S., Recchia, F., Rizzi, D., Romano, C., Rossello, R., Rossini, C., Salvucci, G., Sanna, V., Santini, A., Saracchini, S., Savastano, C., Scambia, G., Schettini, F., Schiavone, P., Schirone, A., Seles, E., Signoriello, S., Signoriello, G., Silva, R. R., Silvestri, A., Simeon, V., Spagnoletti, I., Tamberi, S., Teragni, C., Thalmann, V., Thomas, R., Thomas, G., Tienghi, A., Tinari, N., Tinessa, V., Tomei, F., Tonini, G., Torri, V., Traficante, D., Tudini, M., Turazza, M., Vignoli, R., Vitale, M. G., Zacchia, A., Zagarese, P., Zanni, A., Zavallone, L., Zavettieri, M., Zoboli, A. & Investigators, GIM., 2018, In : The Lancet Oncology. 19, 4, p. 474-485 12 p.

Research output: Contribution to journalArticle

A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma

Gadducci, A., Grosso, F., Scambia, G., Raspagliesi, F., Colombo, N., Grignani, G., Casali, P., Sanfilippo, R., Buonadonna, A., Santoro, A., Bruzzone, M., Artioli, G., Lorusso, D., Biagioli, E., Fossati, R., Galli, F., Negri, E., Rulli, E., Torri, V. & D’Incalci, M., 2018, In : British Journal of Cancer. 119, 5, p. 565-571 7 p.

Research output: Contribution to journalArticle

trabectedin
Leiomyosarcoma
docetaxel
gemcitabine
Drug Therapy

A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma

Gadducci, A., Grosso, F., Scambia, G., Raspagliesi, F., Colombo, N., Grignani, G., Casali, P., Sanfilippo, R., Buonadonna, A., Santoro, A., Bruzzone, M., Artioli, G., Lorusso, D., Biagioli, E., Fossati, R., Galli, F., Negri, E., Rulli, E., Torri, V. & D’Incalci, M., 2018, In : British Journal of Cancer. 119, 5, p. 565-571 7 p.

Research output: Contribution to journalArticle

A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma

Gadducci, A., Grosso, F., Scambia, G., Raspagliesi, F., Colombo, N., Grignani, G., Casali, P., Sanfilippo, R., Buonadonna, A., Santoro, A., Bruzzone, M., Artioli, G., Lorusso, D., Biagioli, E., Fossati, R., Galli, F., Negri, E., Rulli, E., Torri, V. & D’Incalci, M., 2018, In : British Journal of Cancer. 119, 5, p. 565-571 7 p.

Research output: Contribution to journalArticle

trabectedin
Leiomyosarcoma
docetaxel
gemcitabine
Drug Therapy
2 Citations (Scopus)

A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma

Gadducci, A., Grosso, F., Scambia, G., Raspagliesi, F., Colombo, N., Grignani, G., Casali, P., Sanfilippo, R., Buonadonna, A., Santoro, A., Bruzzone, M., Artioli, G., Lorusso, D., Biagioli, E., Fossati, R., Galli, F., Negri, E., Rulli, E., Torri, V. & D’Incalci, M., 2018, In : British Journal of Cancer. 119, 5, p. 565-571 7 p.

Research output: Contribution to journalArticle

trabectedin
Leiomyosarcoma
docetaxel
gemcitabine
Drug Therapy

Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME)

collaborators, TYME. N., Imbimbo, M., Ottaviano, M., Vitali, M., Fabbri, A., Leuzzi, G., Fiore, M., Franceschini, D., Pasello, G., Perrino, M., Schiavon, M., Pruneri, G., Dei Tos, A. P., Sangalli, C., Garassino, M. C., Berardi, R., Alessi, A., Calareso, G., Petrini, I., Scorsetti, M. & 13 others, Scotti, V., Rosso, L., Rea, F., Pastorino, U., Casali, P. G., Ramella, S., Ricardi, U., Abate-Daga, L., Torri, V., Trama, A., Palmieri, G., Marino, M. & Zucali, P. A., Dec 1 2018, In : Cancer Treatment Reviews. 71, p. 76-87 12 p.

Research output: Contribution to journalArticle

Practice Management
Practice Guidelines
Neoplasms
Neoplasm Staging
Italy

Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME)

Imbimbo, M., Ottaviano, M., Vitali, M., Fabbri, A., Leuzzi, G., Fiore, M., Franceschini, D., Pasello, G., Perrino, M., Schiavon, M., Pruneri, G., Dei Tos, A. P., Sangalli, C., Garassino, M. C., Berardi, R., Alessi, A., Calareso, G., Petrini, I., Scorsetti, M., Scotti, V. & 12 others, Rosso, L., Rea, F., Pastorino, U., Casali, P. G., Ramella, S., Ricardi, U., Abate-Daga, L., Torri, V., Trama, A., Palmieri, G., Marino, M. & Zucali, P. A., 2018, In : Cancer Treatment Reviews. 71, p. 76-87 12 p.

Research output: Contribution to journalArticle

Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME)

Imbimbo, M., Ottaviano, M., Vitali, M., Fabbri, A., Leuzzi, G., Fiore, M., Franceschini, D., Pasello, G., Perrino, M., Schiavon, M., Pruneri, G., Dei Tos, A. P., Sangalli, C., Garassino, M. C., Berardi, R., Alessi, A., Calareso, G., Petrini, I., Scorsetti, M., Scotti, V. & 13 others, Rosso, L., Rea, F., Pastorino, U., Casali, P. G., Ramella, S., Ricardi, U., Abate-Daga, L., Torri, V., Trama, A., Palmieri, G., Marino, M., Zucali, P. A. & collaborators, TYME. N., Dec 2018, In : Cancer Treatment Reviews. 71, p. 76-87 12 p.

Research output: Contribution to journalArticle

Practice Management
Practice Guidelines
Neoplasms
Neoplasm Staging
Italy
9 Citations (Scopus)

Brain Gliomas: Multicenter Standardized Assessment of Dynamic Contrast-enhanced and Dynamic Susceptibility Contrast MR Images

Anzalone, N., Castellano, A., Cadioli, M., Conte, G. M., Cuccarini, V., Bizzi, A., Grimaldi, M., Costa, A., Grillea, G., Vitali, P., Aquino, D., Terreni, M. R., Torri, V., Erickson, B. J. & Caulo, M., Jun 1 2018, In : Radiology. 287, 3, p. 933-943 11 p.

Research output: Contribution to journalArticle

Glioma
Contrast Media
Magnetic Resonance Spectroscopy
Brain
Magnetic Resonance Imaging

Brain Gliomas: Multicenter Standardized Assessment of Dynamic Contrast-enhanced and Dynamic Susceptibility Contrast MR Images

Anzalone, N., Castellano, A., Cadioli, M., Conte, G. M., Cuccarini, V., Bizzi, A., Grimaldi, M., Costa, A., Grillea, G., Vitali, P., Aquino, D., Terreni, M. R., Torri, V., Erickson, B. J. & Caulo, M., Jun 1 2018, In : Radiology. 287, 3, p. 933-943 11 p.

Research output: Contribution to journalArticle

Glioma
Contrast Media
Magnetic Resonance Spectroscopy
Brain
Magnetic Resonance Imaging

Brain Gliomas: Multicenter Standardized Assessment of Dynamic Contrast-enhanced and Dynamic Susceptibility Contrast MR Images

Anzalone, N., Castellano, A., Cadioli, M., Conte, G. M., Cuccarini, V., Bizzi, A., Grimaldi, M., Costa, A., Grillea, G., Vitali, P., Aquino, D., Terreni, M. R., Torri, V., Erickson, B. J. & Caulo, M., 2018, In : Radiology. 287, 3, p. 933-943 11 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Choosing the best chemotherapy agent to boost immune checkpoint inhibition activity

Garassino, M. C., Torri, V., Colombo, M. P. & Sica, A., Oct 15 2018, In : Cancer Research. 78, 20, p. 5729-5730 2 p.

Research output: Contribution to journalArticle

Drug Therapy
Weapons
Paclitaxel
Immunity
Neoplasms
89 Citations (Scopus)

Duration of adjuvant chemotherapy for stage III colon cancer

Grothey, A., Sobrero, A. F., Shields, A. F., Yoshino, T., Paul, J., Taieb, J., Souglakos, J., Shi, Q., Kerr, R., Labianca, R., Meyerhardt, J. A., Vernerey, D., Yamanaka, T., Boukovinas, I., Meyers, J. P., Renfro, L. A., Niedzwiecki, D., Watanabe, T., Torri, V., Saunders, M. & 3 others, Sargent, D. J., Andre, T. & Iveson, T., Mar 29 2018, In : New England Journal of Medicine. 378, 13, p. 1177-1188 12 p.

Research output: Contribution to journalArticle

oxaliplatin
Adjuvant Chemotherapy
Colonic Neoplasms
Confidence Intervals
Therapeutics

Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study

Garassino, M. C., Cho, B-C., Kim, J-H., Mazières, J., Vansteenkiste, J., Lena, H., Corral Jaime, J., Gray, J. E., Powderly, J., Chouaid, C., Bidoli, P., Wheatley-Price, P., Park, K., Soo, R. A., Huang, Y., Wadsworth, C., Dennis, P. A., Rizvi, N. A., Paz-Ares Rodriguez, L., Novello, S. & 133 others, Hiret, S., Schmid, P., Laack, E., Califano, R., Maemondo, M., Kim, S-W., Chaft, J., Vicente Baz, D., Berghmans, T., Kim, D-W., Surmont, V., Reck, M., Han, J-Y., Holgado Martin, E., Belda Iniesta, C., Oe, Y., Chella, A., Chopra, A., Robinet, G., Soto Parra, H., Thomas, M., Cheema, P., Katakami, N., Su, W-C., Kim, Y-C., Wolf, J., Lee, J-S., Saka, H., Milella, M., Ramos Garcia, I., Sibille, A., Yokoi, T., Kang, E. J., Atagi, S., Spaeth-Schwalbe, E., Nishio, M., Imamura, F., Gabrail, N., Veillon, R., Derijcke, S., Maeda, T., Zylla, D., Kubiak, K., Santoro, A., Uy, M. N., Lucien Geater, S., Italiano, A., Kowalski, D., Barlesi, F., Chen, Y-M., Spigel, D., Chewaskulyong, B., Garcia Gomez, R., Alvarez Alvarez, R., Yang, C-H., Hsia, T-C., Denis, F., Sakai, H., Vincent, M., Goto, K., Bosch-Barrera, J., Weiss, G., Canon, J-L., Scholz, C., Aglietta, M., Kemmotsu, H., Azuma, K., Bradbury, P., Feld, R., Chachoua, A., Jassem, J., Juergens, R., Palmero Sanchez, R., Malcolm, A., Vrindavanam, N., Kubota, K., Waller, C., Waterhouse, D., Coudert, B., Mark, Z., Satouchi, M., Chang, G-C., Herzmann, C., Chaudhry, A., Giridharan, S., Hesketh, P., Ikeda, N., Boccia, R., Iannotti, N., Haigentz, M., Reynolds, J., Querol, J., Nakagawa, K., Sugawara, S., Tan, E. H., Hirashima, T., Gettinger, S., Kato, T., Takeda, K., Juan Vidal, O., Mohn-Staudner, A., Panwalkar, A., Daniel, D., Kobayashi, K., Ladrera, G. E. I., Schulte, C., Sebastian, M., Cernovska, M., Coupkova, H., Havel, L., Pauk, N., Singh, J., Murakami, S., Csoszi, T., Losonczy, G., Price, A., Anderson, I., Iqbal, M., Torri, V., Juhasz, E., Khanani, S., Koubkova, L., Levy, B., Page, R., Bocskei, C., Crinò, L., Einspahr, D., Hagenstad, C., Juat, N., Overton, L., Garrison, M., Szalai, Z. & Investigators, ATLANTIC., 2018, In : The Lancet Oncology. 19, 4, p. 521-536 16 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study

Cazzaniga, M., Verusio, C., Ciccarese, M., Fumagalli, A., Sartori, D., Ancona, C., Airoldi, M., Moretti, G., Ficorella, C., Arcangeli, V., Diodati, L., Zambelli, A., Febbraro, A., Generali, D., Pistelli, M., Garrone, O., Musolino, A., Vici, P., Maur, M., Mentuccia, L. & 19 others, La Verde, N., Bianchi, G., Artale, S., Blasi, L., Piezzo, M., Atzori, F., Turletti, A., Benedetto, C., Cursano, M. C., Fabi, A., Gebbia, V., Schirone, A., Palumbo, R., Ferzi, A., Frassoldati, A., Scavelli, C., Clivio, L., Torri, V. & On behalf of The EVA Study Group, B. O. T. EVA. S. G., Aug 1 2018, In : Oncotarget. 9, 61, p. 31877-31887 11 p.

Research output: Contribution to journalArticle

exemestane
Extravehicular Activity
Breast Neoplasms
Stomatitis
Exanthema

RELEVENT Trial

Imbimbo, M., Vitali, M., Fabbri, A., Ottaviano, M., Pasello, G., Petrini, I., Palmieri, G., Berardi, R., Zucali, P., Ganzinelli, M., Marabese, M., Broggini, M., Marino, M., Trama, A., Rulli, E., Hollander, L., Pruneri, G., Torri, V. & Garassino, M. C., Sep 2018, In : Clinical Lung Cancer. 19, 5, p. e811-e814

Research output: Contribution to journalArticle

RELEVENT Trial: Phase II Trial of Ramucirumab, Carboplatin, and Paclitaxel in Previously Untreated Thymic Carcinoma/B3 Thymoma With Area of Carcinoma

Imbimbo, M., Vitali, M., Fabbri, A., Ottaviano, M., Pasello, G., Petrini, I., Palmieri, G., Berardi, R., Zucali, P., Ganzinelli, M., Marabese, M., Broggini, M., Marino, M., Trama, A., Rulli, E., Hollander, L., Pruneri, G., Torri, V. & Garassino, M. C., Sep 2018, In : Clinical Lung Cancer. 19, 5, p. e811-e814

Research output: Contribution to journalArticle

Thymoma
Carboplatin
Paclitaxel
Carcinoma
Safety

RELEVENT Trial: Phase II Trial of Ramucirumab, Carboplatin, and Paclitaxel in Previously Untreated Thymic Carcinoma/B3 Thymoma With Area of Carcinoma

Imbimbo, M., Vitali, M., Fabbri, A., Ottaviano, M., Pasello, G., Petrini, I., Palmieri, G., Berardi, R., Zucali, P., Ganzinelli, M., Marabese, M., Broggini, M., Marino, M., Trama, A., Rulli, E., Hollander, L., Pruneri, G., Torri, V. & Garassino, M. C., Sep 2018, In : Clinical Lung Cancer. 19, 5, p. e811-e814

Research output: Contribution to journalArticle

Thymoma
Carboplatin
Paclitaxel
Carcinoma
Safety

RELEVENT Trial: Phase II Trial of Ramucirumab, Carboplatin, and Paclitaxel in Previously Untreated Thymic Carcinoma/B3 Thymoma With Area of Carcinoma

Imbimbo, M., Vitali, M., Fabbri, A., Ottaviano, M., Pasello, G., Petrini, I., Palmieri, G., Berardi, R., Zucali, P., Ganzinelli, M., Marabese, M., Broggini, M., Marino, M., Trama, A., Rulli, E., Hollander, L., Pruneri, G., Torri, V. & Garassino, M. C., 2018, In : Clinical Lung Cancer. 19, 5, p. e811-e814

Research output: Contribution to journalArticle

Soluble stroma-related biomarkers of pancreatic cancer

Resovi, A., Bani, M. R., Porcu, L., Anastasia, A., Minoli, L., Allavena, P., Cappello, P., Novelli, F., Scarpa, A., Morandi, E., Falanga, A., Torri, V., Taraboletti, G., Belotti, D. & Giavazzi, R., Aug 2018, In : EMBO Molecular Medicine. 10, 8

Research output: Contribution to journalArticle

Adenocarcinoma
Biomarkers
Area Under Curve
Healthy Volunteers
Chronic Pancreatitis

The Glaucoma Italian Pediatric Study (GIPSy): 3-Year Results

Quaranta, L., Biagioli, E., Riva, I., Galli, F., Poli, D., Rulli, E., Katsanos, A., Longo, A., Uva, M. G., Oddone, F., Torri, V. & Weinreb, R. N., Oct 2018, In : Journal of Glaucoma. 27, 10, p. 856-863 8 p.

Research output: Contribution to journalArticle

dorzolamide
latanoprost
Glaucoma
Pediatrics
Intraocular Pressure

The Glaucoma Italian Pediatric Study (GIPSy): 3-Year Results

Quaranta, L., Biagioli, E., Riva, I., Galli, F., Poli, D., Rulli, E., Katsanos, A., Longo, A., Uva, M. G., Oddone, F., Torri, V. & Weinreb, R. N., Oct 2018, In : Journal of Glaucoma. 27, 10, p. 856-863 8 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)

Visual field loss and vision-related quality of life in the Italian Primary Open Angle Glaucoma Study

Rulli, E., Quaranta, L., Riva, I., Poli, D., Hollander, L., Galli, F., Katsanos, A., Oddone, F., Torri, V., Weinreb, R. N., Varano, L., Carchedi, T., Talarico, S., Parravano, F., Motolese, I., Bagaglia, S. A., Rossi, G. C. M., Lateri, S., Bossolesi, L., Carmassi, L. & 40 others, Rolle, T., Piccini, R., Ratiglia, R., Rossi, A., Gandolfi, S., Tagliavini, V., Ungaro, N., Fossarello, M., Cucca, A., Zucca, I., Uva, M., Bonacci, E., Cardarella, G., Tognetto, D., Vattovani, O., Vallon, P., Iannacone, F., Fontana, L., Marchi, S., Manni, G. L., Jannetta, D., Roberti, G., Rossetti, L., Maggiolo, E., Oneta, O., Sborgia, C., Cantatore, F., Mastropasqua, L., Agnifili, L., Campos, E., Gizzi, C., Giannaccare, G., Pucci, V., Cassamali, M., Costagliola, C., Traverso, C., Scotto, R., Musolino, M., Landi, L. & Bagnis, A., Dec 1 2018, In : Scientific Reports. 8, 1, 619.

Research output: Contribution to journalArticle

Visual Fields
Glaucoma
Quality of Life
National Eye Institute (U.S.)
Ocular Hypertension

Visual field loss and vision-related quality of life in the Italian Primary Open Angle Glaucoma Study

Italian Study Group on QoL in glaucoma, Jan 12 2018, In : Scientific Reports. 8, 1, p. 619

Research output: Contribution to journalArticle

Visual Fields
Glaucoma
Quality of Life
National Eye Institute (U.S.)
Ocular Hypertension
2017
33 Citations (Scopus)

A MALT lymphoma prognostic index

Thieblemont, C., Cascione, L., Conconi, A., Kiesewetter, B., Raderer, M., Gaidano, G., Martelli, M., Laszlo, D., Coiffier, B., Lopez Guillermo, A., Torri, V., Cavalli, F., Johnson, P. W. & Zucca, E., Sep 21 2017, In : Blood. 130, 12, p. 1409-1417 9 p.

Research output: Contribution to journalArticle

Marginal Zone B-Cell Lymphoma
Tissue
Chlorambucil
Hazards
Lymphoid Tissue
31 Citations (Scopus)

Best practices for the management of local-regional recurrent chordoma: A position paper by the Chordoma Global Consensus Group

Stacchiotti, S., Gronchi, A., Fossati, P., Akiyama, T., Alapetite, C., Baumann, M., Blay, J. Y., Bolle, S., Boriani, S., Bruzzi, P., Capanna, R., Caraceni, A., Casadei, R., Colia, V., Debus, J., Delaney, T., Desai, A., Dileo, P., Dijkstra, S., Doglietto, F. & 30 others, Flanagan, A., Froelich, S., Gardner, P. A., Gelderblom, H., Gokaslan, Z. L., Haas, R., Heery, C., Hindi, N., Hohenberger, P., Hornicek, F., Imai, R., Jeys, L., Jones, R. L., Kasper, B., Kawai, A., Krengli, M., Leithner, A., Logowska, I., Martin Broto, J., Mazzatenta, D., Morosi, C., Nicolai, P., Norum, O. J., Picci, P., Radaelli, S., Ricchini, F., Tamborini, E., Torri, V., Vanel, D. & Casali, P. G., 2017, In : Annals of Oncology. 28, 6, p. 1230-1242 13 p.

Research output: Contribution to journalArticle

8 Citations (Scopus)

Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2-) advanced breast cancer patients

Cazzaniga, M. E., Airoldi, M., Arcangeli, V., Artale, S., Atzori, F., Ballerio, A., Bianchi, G. V., Blasi, L., Campidoglio, S., Ciccarese, M., Cursano, M. C., Piezzo, M., Fabi, A., Ferrari, L., Ferzi, A., Ficorella, C., Frassoldati, A., Fumagalli, A., Garrone, O., Gebbia, V. & 20 others, Generali, D., La Verde, N., Maur, M., Michelotti, A., Moretti, G., Musolino, A., Palumbo, R., Pistelli, M., Porpiglia, M., Sartori, D., Scavelli, C., Schirone, A., Turletti, A., Valerio, M. R., Vici, P., Zambelli, A., Clivio, L., Torri, V., of, O. B. & Gervasi, E., Oct 2017, In : Breast. 35, p. 115-121 7 p.

Research output: Contribution to journalArticle

exemestane
Epidermal Growth Factor
Hormones
Breast Neoplasms
Safety
8 Citations (Scopus)

Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2-) advanced breast cancer patients: New insights beyond clinical trials. The EVA study

Cazzaniga, M. E., Airoldi, M., Arcangeli, V., Artale, S., Atzori, F., Ballerio, A., Bianchi, G. V., Blasi, L., Campidoglio, S., Ciccarese, M., Cursano, M. C., Piezzo, M., Fabi, A., Ferrari, L., Ferzi, A., Ficorella, C., Frassoldati, A., Fumagalli, A., Garrone, O., Gebbia, V. & 19 others, Generali, D., La Verde, N., Maur, M., Michelotti, A., Moretti, G., Musolino, A., Palumbo, R., Pistelli, M., Porpiglia, M., Sartori, D., Scavelli, C., Schirone, A., Turletti, A., Valerio, M. R., Vici, P., Zambelli, A., Clivio, L., Torri, V. & on behalf of, Oct 2017, In : Breast. 35, p. 115-121 7 p.

Research output: Contribution to journalArticle

exemestane
Extravehicular Activity
Epidermal Growth Factor
Clinical Trials
Hormones
8 Citations (Scopus)

Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2-) advanced breast cancer patients: New insights beyond clinical trials. The EVA study

Cazzaniga, M. E., Airoldi, M., Arcangeli, V., Artale, S., Atzori, F., Ballerio, A., Bianchi, G. V., Blasi, L., Campidoglio, S., Ciccarese, M., Cursano, M. C., Piezzo, M., Fabi, A., Ferrari, L., Ferzi, A., Ficorella, C., Frassoldati, A., Fumagalli, A., Garrone, O., Gebbia, V. & 20 others, Generali, D., La Verde, N., Maur, M., Michelotti, A., Moretti, G., Musolino, A., Palumbo, R., Pistelli, M., Porpiglia, M., Sartori, D., Scavelli, C., Schirone, A., Turletti, A., Valerio, M. R., Vici, P., Zambelli, A., Clivio, L., Torri, V., of, O. B. & Group, EVA. S., Oct 1 2017, In : Breast. 35, p. 115-121 7 p.

Research output: Contribution to journalArticle

8 Citations (Scopus)

Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study

Cicchiello, F., Riva, F., Cazzaniga, M. E., Pedani, F., Nicolini, M., Butti, C., Liscia, N., Pogliani, C., Capri, G., Alù, M., Febbraro, A., Petrucelli, L., D'Onofrio, L., De Laurentiis, M., Pellegrini, D., Mentuccia, L., Cocciolone, V., Miraglio, E., Bajardi, E., Dester, M. & 49 others, Paternò, E., Guaitoli, G., Ferrarini, I., Gervasi, E., Licata, L., Benedetto, C., Andreis, D., Bordin, E., Ancona, C., Pizzuti, L., Fotia, V., Berardi, R., Airoldi, M., Arcangeli, V., Artale, S., Atzori, F., Ballerio, A., Bianchi, G. V., Blasi, L., Campidoglio, S., Ciccarese, M., Cursano, M. C., Piezzo, M., Fabi, A., Ferrari, L., Ferzi, A., Ficorella, C., Frassoldati, A., Fumagalli, A., Garrone, O., Gebbia, V., Generali, D., La Verde, N., Maur, M., Michelotti, A., Moretti, G., Musolino, A., Palumbo, R., Pistelli, M., Porpiglia, M., Sartori, D., Scavelli, C., Schirone, A., Turletti, A., Valerio, M. R., Vici, P., Zambelli, A., Clivio, L. & Torri, V., 2017, In : Breast. 35, p. 115-121 7 p.

Research output: Contribution to journalArticle

35 Citations (Scopus)

Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy

Zucca, E., Conconi, A., Martinelli, G., Bouabdallah, R., Tucci, A., Vitolo, U., Martelli, M., Pettengell, R., Salles, G., Sebban, C., Guillermo, A. L., Pinotti, G., Devizzi, L., Morschhauser, F., Tilly, H., Torri, V., Hohaus, S., Ferreri, A. J. M., Zachée, P., Bosly, A. & 11 others, Haioun, C., Stelitano, C., Bellei, M., Ponzoni, M., Moreau, A., Jack, A., Campo, E., Mazzucchelli, L., Cavalli, F., Johnson, P. & Thieblemont, C., Jun 10 2017, In : Journal of Clinical Oncology. 35, 17, p. 1905-1912 8 p.

Research output: Contribution to journalArticle

Chlorambucil
Marginal Zone B-Cell Lymphoma
Disease-Free Survival
Appointments and Schedules
Survival
35 Citations (Scopus)

Final results of the IELSG-19 randomized trial of mucosa-associated lymphoid tissue lymphoma: Improved event-free and progression-free survival with rituximab plus chlorambucil versus either chlorambucil or rituximab monotherapy

Zucca, E., Conconi, A., Martinelli, G., Bouabdallah, R., Tucci, A., Vitolo, U., Martelli, M., Pettengell, R., Salles, G., Sebban, C., Lopez Guillermo, A., Pinotti, G., Devizzi, L., Morschhauser, F., Tilly, H., Torri, V., Hohaus, S., Ferreri, A. J., Zachée, P., Bosly, A. & 11 others, Haioun, C., Stelitano, C., Bellei, M., Ponzoni, M., Moreau, A., Jack, A., Campo, E., Mazzucchelli, L., Cavalli, F., Johnson, P. & Thieblemont, C., 2017, In : Journal of Clinical Oncology. 35, 17, p. 1905-1912 8 p.

Research output: Contribution to journalArticle

35 Citations (Scopus)

Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy

Zucca, E., Conconi, A., Martinelli, G., Bouabdallah, R., Tucci, A., Vitolo, U., Martelli, M., Pettengell, R., Salles, G., Sebban, C., Guillermo, AL., Pinotti, G., Devizzi, L., Morschhauser, F., Tilly, H., Torri, V., Hohaus, S., Ferreri, AJM., Zachée, P., Bosly, A. & 11 others, Haioun, C., Stelitano, C., Bellei, M., Ponzoni, M., Moreau, A., Jack, A., Campo, E., Mazzucchelli, L., Cavalli, F., Johnson, P. & Thieblemont, C., 2017, In : Journal of Clinical Oncology. 35, 17, p. 1905-1912 8 p.

Research output: Contribution to journalArticle

Chlorambucil
Marginal Zone B-Cell Lymphoma
Disease-Free Survival
Appointments and Schedules
Survival
2 Citations (Scopus)

Nab-Paclitaxel in Advanced HER2-negative Breast Cancer Patients: Efficacy and Safety Beyond Clinical Trials

Bernardo, A., Palumbo, R., Pedersini, R., Rota Caremoli, E., Gambaro, A. R., Ferzi, A., Riva, F., Grasso, D., Danova, M., Tarenzi, E., Torri, V. & Cazzaniga, M. E., Oct 2017, In : Clinical Breast Cancer. 17, 6, p. 433-440 8 p.

Research output: Contribution to journalArticle

Patient Safety
Clinical Trials
Breast Neoplasms
Appointments and Schedules
Nanoparticles
2 Citations (Scopus)

Nab-Paclitaxel in Advanced HER2-negative Breast Cancer Patients: Efficacy and Safety Beyond Clinical Trials

Bernardo, A., Palumbo, R., Pedersini, R., Rota Caremoli, E., Gambaro, A. R., Ferzi, A., Riva, F., Grasso, D., Danova, M., Tarenzi, E., Torri, V. & Cazzaniga, M. E., Oct 1 2017, In : Clinical Breast Cancer. 17, 6, p. 433-440 8 p.

Research output: Contribution to journalArticle

Patient Safety
Appointments and Schedules
Clinical Trials
Breast Neoplasms
Nanoparticles
11 Citations (Scopus)

Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world

Fanotto, V., Cordio, S., Pasquini, G., Fontanella, C., Rimassa, L., Leone, F., Rosati, G., Santini, D., Giampieri, R., Di Donato, S., Tomasello, G., Silvestris, N., Pietrantonio, F., Battaglin, F., Avallone, A., Scartozzi, M., Lutrino, E. S., Melisi, D., Antonuzzo, L., Pellegrino, A. & 2 others, Torri, V. & Aprile, G., Sep 1 2017, In : Gastric Cancer. 20, 5, p. 825-833 9 p.

Research output: Contribution to journalArticle

Stomach Neoplasms
Drug Therapy
Disease-Free Survival
Therapeutics
Survival

Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world.

Fanotto, V., Cordio, S., Pasquini, G., Fontanella, C., Rimassa, L., Leone, F., Rosati, G., Santini, D., Giampieri, R., Di Donato, S., Tomasello, G., Silvestris, N., Pietrantonio, F., Battaglin, F., Avallone, A., Scartozzi, M., Lutrino, E. S., Melisi, D., Antonuzzo, L., Pellegrino, A. & 2 others, Torri, V. & Aprile, G., Sep 1 2017, In : Gastric Cancer. 20, p. 825-833 9 p.

Research output: Contribution to journalArticle

Stomach Neoplasms
Drug Therapy
Disease-Free Survival
Therapeutics
Survival